Related references
Note: Only part of the references are listed.miR-204 is Dysregulated in Metastatic Prostate Cancer In Vitro
Krassimira Todorova et al.
MOLECULAR CARCINOGENESIS (2016)
ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor
Zineb Mounir et al.
ELIFE (2016)
Androgen receptor and gene network: Micromechanics reassemble the signaling machinery of TMPRSS2-ERG positive prostate cancer cells
Ammad Ahmad Farooqi et al.
CANCER CELL INTERNATIONAL (2014)
Differential Effects of RUNX2 on the Androgen Receptor in Prostate Cancer: Synergistic Stimulation of a Gene Set Exemplified by SNAI2 and Subsequent Invasiveness
Gillian H. Little et al.
CANCER RESEARCH (2014)
TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
Christina Hagglof et al.
PLOS ONE (2014)
Targeting Poly(ADP-Ribose) Polymerase and the c-Myb-Regulated DNA Damage Response Pathway in Castration-Resistant Prostate Cancer
Likun Li et al.
SCIENCE SIGNALING (2014)
Maintaining and reprogramming genomic androgen receptor activity in prostate cancer
Ian G. Mills
NATURE REVIEWS CANCER (2014)
Fundamental Role of microRNAs in Androgen-Dependent Male Reproductive Biology and Prostate Cancerogenesis
Krassimira Todorova et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2013)
Nucleotide resolution analysis of TMPRSS2 and ERG rearrangements in prostate cancer
Christopher Weier et al.
JOURNAL OF PATHOLOGY (2013)
The E2F1/DNMT1 Axis Is Associated With the Development of AR Negative Castration Resistant Prostate Cancer
Conrad David Valdez et al.
PROSTATE (2013)
CD74-dependent Deregulation of the Tumor Suppressor Scribble in Human Epithelial and Breast Cancer Cells
Gergana Metodieva et al.
NEOPLASIA (2013)
ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype
A. M. Smith et al.
CARCINOGENESIS (2012)
Development of a Quantitative Methylation-Specific Polymerase Chain Reaction Method for Monitoring Beta Cell Death in Type 1 Diabetes
Mohamed I. Husseiny et al.
PLOS ONE (2012)
Genome-wide DNA Methylation Events in TMPRSS2-ERG Fusion-Negative Prostate Cancers Implicate an EZH2-Dependent Mechanism with miR-26a Hypermethylation
Stefan T. Boerno et al.
CANCER DISCOVERY (2012)
TMPRSS2-ERG-Mediated Feed-Forward Regulation of Wild-Type ERG in Human Prostate Cancers
Ram-Shankar Mani et al.
CANCER RESEARCH (2011)
A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancer
Jacob Schwartzman et al.
EPIGENETICS (2011)
A Panel of TMPRSS2:ERG Fusion Transcript Markers for Urine-Based Prostate Cancer Detection with High Specificity and Sensitivity
Phuong-Nam Nguyen et al.
EUROPEAN UROLOGY (2011)
Ets-1 is implicated in the regulation of androgen co-regulator FHL2 and reveals specificity for migration, but not invasion, of PC3 prostate cancer cells
Zaki Shaikhibrahim et al.
ONCOLOGY REPORTS (2011)
Repression of Androgen Receptor Transcription through the E2F1/DNMT1 Axis
Conrad David Valdez et al.
PLOS ONE (2011)
Molecular classification of prostate cancer using curated expression signatures
Elke K. Markert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Mechanisms and Functional Consequences of PDEF Protein Expression Loss During Prostate Cancer Progression
David P. Turner et al.
PROSTATE (2011)
Androgen receptor-driven chromatin looping in prostate cancer
Dayong Wu et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2011)
An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
Jindan Yu et al.
CANCER CELL (2010)
TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features
Samson W. Fine et al.
MODERN PATHOLOGY (2010)
Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis
Sanjeev K. Baniwal et al.
MOLECULAR CANCER (2010)
Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions
J. Akech et al.
ONCOGENE (2010)
MicroRNAs Are Mediators of Androgen Action in Prostate and Muscle
Ramesh Narayanan et al.
PLOS ONE (2010)
TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy
Anuradha Gopalan et al.
CANCER RESEARCH (2009)
Gene Networks and microRNAs Implicated in Aggressive Prostate Cancer
Liang Wang et al.
CANCER RESEARCH (2009)
Increased Expression of Androgen Receptor Sensitizes Prostate Cancer Cells to Low Levels of Androgens
Kati K. Waltering et al.
CANCER RESEARCH (2009)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
Histone Deacetylases Are Required for Androgen Receptor Function in Hormone-Sensitive and Castrate-Resistant Prostate Cancer
Derek S. Welsbie et al.
CANCER RESEARCH (2009)
Identification of a region of the DNMT1 methyltransferase that regulates the maintenance of genomic imprints
Ewa Borowczyk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer
Bharathi Laxman et al.
CANCER RESEARCH (2008)
Delineation of TMPRSS2-ERG splice variants in prostate cancer
Ying Hu et al.
CLINICAL CANCER RESEARCH (2008)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer
Bungo Furusato et al.
MODERN PATHOLOGY (2008)
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
G. Attard et al.
ONCOGENE (2008)
A polycomb repression signature in metastatic prostate cancer predicts cancer outcome
Jindan Yu et al.
CANCER RESEARCH (2007)
Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome (Vol 24, pg 3847, 2005)
G. Petrovics et al.
ONCOGENE (2007)
TMPRSS2:: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort (vol 26, pg 4596, 2007)
F. Demichelis et al.
ONCOGENE (2007)
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate
J. Clark et al.
ONCOGENE (2007)
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line:: A new perspective for an old model
Kirsten D. Mertz et al.
NEOPLASIA (2007)
Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer
Bharathi Laxman et al.
NEOPLASIA (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
A model for random sampling and estimation of relative protein abundance in shotgun proteomics
HB Liu et al.
ANALYTICAL CHEMISTRY (2004)
Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs
YQ Sun et al.
NUCLEIC ACIDS RESEARCH (2004)
Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells
ME Wright et al.
MOLECULAR ENDOCRINOLOGY (2003)
The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2
M Saito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
MBD2-MBD3 complex binds to hemi-methylated DNA and forms a complex containing DNMT1 at the replication foci in late S phase
K Tatematsu et al.
GENES TO CELLS (2000)